InflaRx stock trades at 1.49 euros as weekend trading pauses
Published on 11/01/2026 at 12:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat investors should watch
- InflaRx is scheduled to report results on November 3.
- Recent company coverage has focused on izicopan kidney data from two hamster models.
InflaRx stock traded at 1.49 euros on Lang & Schwarz at 13:04 CET on Saturday, October 31, 2026. The quote was unchanged from the preceding Lang & Schwarz reference of 1.49 euros in the available trading snapshot.
Results due next week
InflaRx is scheduled to report results on Tuesday, November 3. The upcoming update gives investors the next opportunity to assess the biotech company's development programs and financial position.
Recent coverage has centered on izicopan, the company's C5a inhibitor. InflaRx presented kidney data from two hamster models dated October 22, according to the company's recent market coverage.
InflaRx at a glance
- Company: InflaRx
- ISIN: NL0012661870
- Ticker: IFRX
- Trading venue: Lang & Schwarz
- Quote: 1.49 euros on October 31, 2026, at 13:04 CET
- Bid: 1.48 euros
- Ask: 1.50 euros
Investors can follow the real-time quote of InflaRx stock as the company approaches its results date.
The AEX index provides the broader Dutch market context.
More news and analyses are available on InflaRx stock.
